ERNA vs GPC · P/E 0.0, rev $582.0K vs P/E 21, rev $23.49B
Eterna Therapeutics Inc (ERNA) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the ERNA and GPC stock pages for the full models.
Not investment advice.